WORLDglobal
SK Bioscience expands global health push, securing funding for RSV antibody
Single source
Updated 3 hours ago
First seen March 18, 2026 16:35:32Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
SK Bioscience said Wednesday it has secured funding from the Research Investment for Global Health Technology Foundation to advance the clinical development of RSM01, a monoclonal antibody candidate aimed at preventing respiratory syncytial virus, strengthening its presence in the global infectious disease market. According to SK Bioscience, the RIGHT Foundation agreed to provide 4 billion won ($2.7 million) — the largest grant available per project — to the Korean vaccine developer. With the fu